Cargando…
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis
Hereditary spherocytosis (HS) is the most common, nonimmune, hereditary, chronic hemolytic anemia after hemoglobinopathies. The genetic defects in membrane function causing HS lead to perturbation of the RBC metabolome, with altered glycolysis. In mice genetically lacking protein 4.2 (4.2(–/–); Epb4...
Autores principales: | Matte, Alessandro, Wilson, Anand B., Gevi, Federica, Federti, Enrica, Recchiuti, Antonio, Ferri, Giulia, Brunati, Anna Maria, Pagano, Mario Angelo, Russo, Roberta, Leboeuf, Christophe, Janin, Anne, Timperio, Anna Maria, Iolascon, Achille, Gremese, Elisa, Dang, Lenny, Mohandas, Narla, Brugnara, Carlo, De Franceschi, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619498/ https://www.ncbi.nlm.nih.gov/pubmed/37676741 http://dx.doi.org/10.1172/jci.insight.172656 |
Ejemplares similares
-
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023) -
P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.
por: Matte’, Alessandro, et al.
Publicado: (2023) -
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
por: Federti, Enrica, et al.
Publicado: (2023) -
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis
por: Federti, Enrica, et al.
Publicado: (2017) -
New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019)